Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
GU tumors
May 14, 2024, 05:28 |
Cancer Types
Rhabdomyosarcoma: What patients and caregivers should know about
What is Rhabdomyosarcoma? Rhabdomyosarcoma is a type of soft tissue sarcoma that typically begins in…
May 14, 2024, 03:26 |
Blog
Top 10 Abstracts at ESMO Breast 24 by Paolo Tarantino
Paolo Tarantino made the following post on LinkedIn: "Less than 48h to ESMO Breast 24:…
May 14, 2024, 03:07 |
Blog
Erika Hamilton: Fantastic list for ESMO Breast 24
Erika Hamilton shared a post by Paolo Tarantino on LinkedIn, adding: "Fantastic list for ESMO Breast 24.…
May 13, 2024, 13:41 |
Insight
Innovative stem cell model provides insight into childhood cancer origins
Researchers from the University of Sheffield and St. Anna Children’s Cancer Research Institute have created…
May 13, 2024, 08:24 |
Blog
Monica Bertagnolli: AI Tool Has Promise for Matching Cancer Drugs to Patients
Monica Bertagnolli shared a post on LinkedIn: ''AI Tool Using Single-Cell Data Has Promise for Optimally…
May 13, 2024, 05:06 |
Insight
Sylvester Researchers Develop a Nanoparticle That Can Penetrate the Blood-Brain Barrier
Sylvester scientists hope their method, which shows early promise in preclinical models, may someday target…
May 12, 2024, 17:41 |
Insight
Marco Donia: Circadian rhythm, tumor infiltration of CD8+ T cells, and cancer immunotherapy
Marco Donia, Clinical Research Associate Professor at the University of Copenhagen, shared on LinkedIn: “Circadian…
May 12, 2024, 16:18 |
Insight
Patrick Hwu: Insights into CAR design and optimal coupling to inhibit the PD-L1/PD-1 axis
Patrick Hwu shared on X/Twitter: "Science Saturday T-cells gene-modified with chimeric antigen receptors (CAR) can be…
May 12, 2024, 03:12 |
Blog
Misty Dawn Shields: Groundbreaking study challenging the dogma of 'YAP1' neuroendocrine subtype in SCLC
Misty Dawn Shields, Assistant Professor of Clinical Medicine, Division of Hematology/Oncology at IU School of…
May 10, 2024, 17:49 |
Drugs
Piotr Wysocki: Relatlimab does not improve the activity of nivolumab plus chemotherapy
Piotr Wysocki recently posted on LinkedIn: "RELATIVITY-060 was an open-label phase II study investigating the…
58
59
60
61
62
All:
744
Posts:
591 - 600
Agenus CEO Dr. Garo Armen Honored with WITSA Eminent Person 2024 Award for Cancer Immunotherapy Breakthrough
Vivek Subbiah: Key publications leading to Nobel Prize 2024, published in 1993
Victor Ambros and Gary Ruvkun Awarded 2024 Nobel Prize in Medicine for MicroRNA Discovery
Dr. Zainab Shinkafi-Bagudu: Advocating for Equity in Cancer Care - UICC Presidential Candidacy
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube